{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:23:41Z","timestamp":1785018221057,"version":"3.55.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Haemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome characterised by uncontrolled immune activation and multi-organ dysfunction. Whilst initially described in paediatric populations, HLH is increasingly recognised in critically ill adults, often triggered by malignancies, infections, or autoimmune diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-centre retrospective study analysed 43 adult patients with HLH admitted to the ICU between 2008 and 2024. Clinical characteristics, laboratory parameters, organ support requirements, and outcomes were assessed. Temporal trends in routine parameters surrounding HLH diagnosis were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age was 45\u202fyears (IQR: 33\u201360), and 65% were male. Respiratory failure (62.8%) and sepsis (41.9%) were the leading causes of ICU admission. Disease severity was high, with a median SOFA score of 14 (IQR: 11\u201317), and ICU mortality reached 65.1%. Invasive mechanical ventilation was required in 83.7% of patients, and continuous renal replacement therapy in 72.1%. Ferritin levels were markedly elevated, with a median peak of 25,045\u202f\u03bcg\/l (IQR: 12,771\u201394,586), with 93% of patients exceeding 6,000\u202f\u03bcg\/l. The median HScore was 245 (IQR: 210\u2013273) and did not differ significantly between survivors and non-survivors (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.64).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HLH in adult ICUs carries high mortality and demands extensive organ support. Existing diagnostic scores provide limited bedside guidance, highlighting the need for ICU-specific validation and improved prognostic markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1641659","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:55:55Z","timestamp":1761720955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Haemophagocytic lymphohistiocytosis in critically ill adults: a single-centre retrospective ICU cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Markus","family":"Haar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Stadermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Roedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tintelnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gleibs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Nierhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paymon","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/pbc.22359","article-title":"Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race","volume":"54","author":"Niece","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2665-9913(23)00273-4","article-title":"Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH across Speciality collaboration (HiHASC) consensus guideline","volume":"6","author":"Cox","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"735796","DOI":"10.3389\/fmed.2021.735796","article-title":"High mortality of HLH in ICU regardless etiology or treatment","volume":"8","author":"Bichon","year":"2021","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MOH.0b013e3282f97f88","article-title":"When T cells and macrophages do not talk: the hemophagocytic syndromes","volume":"15","author":"Arceci","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1097\/MPH.0000000000000073","article-title":"Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma","volume":"36","author":"Ciambotti","year":"2014","journal-title":"JPHO"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/ijms25052762","article-title":"Late onset of primary Hemophagocytic Lymphohistiocytosis (HLH) with a novel constellation of compound heterozygosity involving two missense variants in the PRF1 gene","volume":"25","author":"Stadermann","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive Hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13054-020-02941-3","article-title":"Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore","volume":"24","author":"Knaak","year":"2020","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10875-024-01797-4","article-title":"Hyperferritinemia screening to aid identification and differentiation of patients with Hyperinflammatory disorders","volume":"45","author":"Carol","year":"2025","journal-title":"J Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/ejh.14263","article-title":"Marked hyperferritinemia in critically ill cancer patients","volume":"113","author":"Liedgens","year":"2024","journal-title":"Eur J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How i treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/joim.20065","article-title":"Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteria","volume":"297","author":"Lachmann","year":"2025","journal-title":"J Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ejh.14185","article-title":"Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients","volume":"112","author":"Nyvlt","year":"2024","journal-title":"Eur J Haematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-010-1936-z","article-title":"Critical care management of patients with hemophagocytic lymphohistiocytosis","volume":"36","author":"Buyse","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new simplified acute physiology score (SAPS II) based on a European\/north American multicenter study","volume":"270","author":"Gall","year":"1993","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4266\/kjccm.2009.24.1.4","article-title":"The prognostic utility of the simplified acute physiology score II (SAPS II) and the sequential organ failure assessment (SOFA) score for hemato-oncology patients admitted to the intensive care unit","volume":"24","author":"Park","year":"2009","journal-title":"Korean J Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0168948","DOI":"10.1371\/journal.pone.0168948","article-title":"Predictive performance of the simplified acute physiology score (SAPS) II and the initial sequential organ failure assessment (SOFA) score in acutely ill intensive care patients: post-hoc analyses of the SUP-ICU inception cohort study","volume":"11","author":"Granholm","year":"2016","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood.2023020715","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival","volume":"143","author":"L\u00f6fstedt","year":"2024","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter","year":"2024","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic syndrome: macrophage activation syndrome, still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","article-title":"Hyperferritinemia in critically ill patients*","volume":"48","author":"Lachmann","year":"2020","journal-title":"Crit Care Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s00134-011-2248-7","article-title":"Impact of hypoxic hepatitis on mortality in the intensive care unit","volume":"37","author":"Fuhrmann","year":"2011","journal-title":"Intensive Care Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13613-018-0356-z","article-title":"Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis","volume":"8","author":"den Broecke","year":"2018","journal-title":"Ann Intensive Care"},{"key":"ref32","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00134-015-4054-0","article-title":"Cholestatic liver (dys)function during sepsis and other critical illnesses","volume":"42","author":"Jenniskens","year":"2016","journal-title":"Intensiv Care Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease Cardiohepatic interactions","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"JACC Heart Fail"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/jcm14041220","article-title":"Parenteral nutrition-induced liver function complications: incidence, risk factors, and prognosis","volume":"14","author":"Park","year":"2025","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13613-017-0337-7","article-title":"Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients?","volume":"7","author":"Dewitte","year":"2017","journal-title":"Ann Intensive Care"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13613-025-01447-x","article-title":"Thrombocytopenia in the intensive care unit: diagnosis and management","volume":"15","author":"P\u00e8ne","year":"2025","journal-title":"Ann Intensive Care"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s40001-024-01887-4","article-title":"The incidence and factors associated with anemia in elective surgical patients admitted to a surgical intensive care unit: a retrospective cohort study","volume":"29","author":"Wubet","year":"2024","journal-title":"Eur J Med Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e0252206","DOI":"10.1371\/journal.pone.0252206","article-title":"Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction","volume":"16","author":"Belok","year":"2021","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12882-023-03225-y","article-title":"Body temperature and infection in critically ill patients on continuous kidney replacement therapy","volume":"24","author":"Challener","year":"2023","journal-title":"BMC Nephrol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/bloodadvances.2021004287","article-title":"IFN-\u03b3 signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS","volume":"5","author":"Lin","year":"2021","journal-title":"Blood Adv"},{"key":"ref42","first-page":"72","article-title":"Cytokine profiles as novel diagnostic markers of Epstein-Barr virus\u2013associated hemophagocytic lymphohistiocytosis in children","volume-title":"J Crit Care","author":"Han","year":"2017"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2024.11.029","article-title":"Features of hyperinflammation link the biology of Epstein-Barr virus infection and cytokine storm syndromes","volume":"155","author":"Liu","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2169\/internalmedicine.55.6524","article-title":"Plasma levels of Presepsin (soluble CD14-subtype) as a novel prognostic marker for Hemophagocytic syndrome in hematological malignancies","volume":"55","author":"Nanno","year":"2015","journal-title":"Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00277-011-1239-7","article-title":"Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome","volume":"91","author":"Tabata","year":"2012","journal-title":"Ann Hematol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in Hemophagocytic Lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"105414","DOI":"10.1016\/j.ebiom.2024.105414","article-title":"Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality","volume":"109","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"EBioMedicine"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/diagnostics13050983","article-title":"Multisystem inflammatory syndrome in adults associated with recent infection with COVID-19","volume":"13","author":"Zahornacky","year":"2023","journal-title":"Diagnostics"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1641659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:55:56Z","timestamp":1761720956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1641659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":48,"alternative-id":["10.3389\/fmed.2025.1641659"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1641659","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1641659"}}